Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.45 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | ACHE | P22303 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | MC4R | P32245 | 1/20 | 0.41 |
| ▸ | SCN4A | P35499 | 1/20 | 0.41 |
| ▸ | MC3R | P41968 | 1/20 | 0.41 |
| ▸ | HTR3A | P46098 | 1/20 | 0.41 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.41 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.41 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL2864880 | 0.97 | CYP1A2 (0.43) | CYP1A2CYP2A6TSHRACHEALDH1A1 | |
| SCHEMBL27839905 | 0.97 | CYP1A2 (0.43) | CYP1A2CYP2A6TSHRACHEALDH1A1 | |
| Benzene SCHEMBL28199279 | 0.97 | CYP1A2 (0.43) | CYP1A2CYP2A6TSHRACHEALDH1A1 | |
| SCHEMBL8439291 | 0.87 | CD44 (0.52) | CYP1A2CYP2A6TSHRACHEALDH1A1 | |
| SCHEMBL4648220 | 0.84 | RAPGEF4 (0.41) | CYP1A2CYP2A6TSHRACHEALDH1A1 | |
| SCHEMBL9228264 | 0.82 | ACHE (0.50) | CYP1A2CYP2A6TSHRACHEALDH1A1 | |
| SCHEMBL10814735 | 0.82 | TRPA1 (0.52) | CYP1A2TSHRALDH1A1CA1CA2 | |
| SCHEMBL11426617 | 0.82 | ALDH1A1 (0.50) | CYP1A2CYP2A6TSHRACHEALDH1A1 | |
| SCHEMBL11663384 | 0.82 | GAA (0.52) | ALDH1A1MAPTL3MBTL1GAAMEN1 | |
| SCHEMBL8229219 | 0.82 | CD44 (0.52) | CYP1A2CYP2A6TSHRACHEALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 360 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118955264-A | Method for preparing p-benzoquinone compound by oxidizing aniline compound | 浙江大学 | 2024-11-15 | — | — | CN | claimed |
| US-20200369689-A1 | Arylaminosilane Compound, Propylene Polymerization Catalyst And Preparation Thereof | PETROCHINA COMPANY LIMITED (CN) | 2020-11-26 | — | — | US | claimed |
| CN-111978346-A | Arylamine silane compound, propylene polymerization catalyst, preparation and application thereof | 中国石油天然气股份有限公司 | 2020-11-24 | — | — | CN | claimed |
| EP-2313481-A2 | PRODUCTION PROCESS OF UNLEADED HIGH OCTANE NUMBER GASOLINE, AND SO OBTAINED GASOLINES | CHIMEC S.P.A. (IT) | 2011-04-27 | — | — | EP | claimed |
| WO-2010001341-A2 | PRODUCTION PROCESS OF UNLEADED HIGH OCTANE NUMBER GASOLINE, AND SO OBTAINED GASOLINES | CHIMEC S.P.A. (IT) | 2010-01-07 | — | — | WO | claimed |
| US-12503593-B2 | Curable thermosetting composition including poly(arylene ether) copolymer | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2025-12-23 | — | — | US | disclosed |
| WO-2025224622-A1 | POLYFUNCTIONAL POLY(ARYLENE ETHER) AND METHOD FOR THE MANUFACTURE THEREOF | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2025-10-30 | — | — | WO | disclosed |
| WO-2025224628-A1 | POLYFUNCTIONAL POLY(ARYLENE ETHERS) AND CURABLE COMPOSITIONS THEREOF | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2025-10-30 | — | — | WO | disclosed |
| WO-2025224626-A1 | THERMOPLASTIC POLYURETHANE AND ASSOCIATED METHOD AND ARTICLE | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2025-10-30 | — | — | WO | disclosed |
| US-20250333561-A1 | POLY(ARYLENE ETHER) COMPOSITIONS | SHPP GLOBAL TECH BV (NL) | 2025-10-30 | — | — | US | disclosed |
| WO-2025224623-A1 | POLYFUNCTIONAL POLY(ARYLENE ETHERS) AND COPOLYMERS THEREOF | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2025-10-30 | — | — | WO | disclosed |
| WO-2025224624-A1 | CURABLE COMPOSITION AND CURED COMPOSITIONS DERIVED THEREFROM | SHPP GLOBAL TECHNOLOGIES B.V. (NL) | 2025-10-30 | — | — | WO | disclosed |
| US-4237068-A | Primary aminoacylanilides | ASTRA PHARMACEUTICAL PRODUCTS, INC. (US) | 1980-12-02 | — | — | US | disclosed |
| US-4218477-A | LONG LASTING ORAL AGENTS | ASTRA PHARMACEUTICAL PRODUCTS, INC. (US) | 1980-08-19 | — | — | US | disclosed |
| US-4188341-A | Process for the production of (substituted) 2,6-dimethylanilines | CIBA-GEIGY CORPORATION (US) | 1980-02-12 | — | — | US | disclosed |
| US-4117165-A | ANTIULCER, HYPOTENSIVE AGENTS | WILLIAM H. RORER, INC. (US) | 1978-09-26 | — | — | US | disclosed |
| US-4115564-A | Treatment of diarrhea with amidinoureas | WILLIAM H. RORER, INC. (US) | 1978-09-19 | — | — | US | disclosed |
| US-4101575-A | FUNGICIDES, BACTERICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1978-07-18 | — | — | US | disclosed |
| US-4093742-A | Anti-hypertensive polyhaloisopropyl-substituted arylureas | SCHERING CORPORATION (US) | 1978-06-06 | — | — | US | disclosed |
| US-4025652-A | ANTIDIARRHEA AGENTS | WILLIAM H. RORER, INC. (US) | 1977-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200369689-A1 | Arylaminosilane Compound, Propylene Polymerization Catalyst And Preparation Thereof | RPS8, PARP8, PRMT8 | CYP1A2 1541/4885CYP2A6 2708/4885TSHR 912/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.